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1. Introduction 
In the last few years, evidence has been accumu- 
lated showing that gene expression in eukaryotic 
cells is not only regulated at the level of transcription, 
but also at post-transcriptional steps (reviewed [I]). 
Tyrosine aminotransferase (TAT, EC 2.6.1.5.) 
has several distinctive features which have made this 
enzyme a convenient model for investigation of 
protein synthesis in hepatoma cells [2,3] . As an 
approach to the problem of regulation of TAT by 
glucocorticoids, we investigated the synthesis of the 
enzyme in cell-free systems where the translational 
control of specific mRNAs and the mechanisms in 
post-translational processing could be studied in detail. 
In this paper, we have examined the in vitro 
synthesis of TAT in a homologous cell-free system 
from dexamethasone-induced or uninduced hepatoma 
tissue culture (HTC) cells. Since the rate of TAT 
synthesis is greater in extracts prepared from induced 
cells than from uninduced cells, we tried to deter- 
mine which cellular components are required for the 
expression of this increased rate of synthesis. Our 
results show that induction enhances largely the TAT 
synthetic activity of the polysomal fraction; in addi- 
tion, the soluble fraction from induced cells contains 
a dialysable component which optimizes TAT specific 
mRNA translation. These results are consistent with 
the observations made in whole cells which suggest 
that enzyme induction results from an increase in 
enzyme-specific mRNA and that TAT synthesis is 
also regulated at the translational level [4] . 
2. Materials and methods 
2.1. Reagents 
The synthetic glucocorticoid, dexamethasone, was 
kindly provided by Roussel-UCLAF Co. (Romainville). 
[3H] Leucine (40 Ci/mmol) was purchased from CEA 
(Paris). Pyruvate kinase, aurintricarboxylic acid and 
spermine’were products from Sigma (St Louis, MO.). 
Tissue culture media were obtained from Grand Island 
Biological Co. 
2.2. Growth of cells 
Suspension cultures of HTC cells were grown in 
S-77 media with 10% calf-serum [S] . For hormone 
induction, dexamethasone was added to final cont. 
1 0V6 M, 12 h before harvesting the cells. TAT enzymic 
activity was assayed by the method in [6]. Protein con- 
centration was determined by the Lowry method [7] . 
2.3. Prepamtion of ‘S-20’20 000 X g supematant 
The cells were harvested by centrifugation at room 
temperature at a density of 4-6 X lO’/ml and wash- 
ed twice, once with ice-cold 0.14 M NaCl and then 
with buffer A (2.5 mM Tris-HCl, pH 7.6,25 mM 
KCl, 5 mM MgC12). The cell pellet was resuspended 
in 1 vol. buffer and subsequent steps were performed 
at 4°C. After hypotonic swelling for 10 min, the cells 
were homogenised with 20 strokes in a Potter-Braun 
tissue grinder with a tight-fitting pestle. The homo- 
genate was brought to 0.25 M sucrose (by adding 
about 0.3 ~012 M sucrose solution), and centrifuged 
at 20 000 X g for 20 min. The overlaying lipid layer 
was removed and the remaining supematant ‘S-20’ 
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fraction used in the amino acid incorporating system 
as in [8]. 
2.4. ~e~arat~o~ of d~ly~b~e factors 
The pellet of induced cells was homogenised in
10% strength buffer A without sucrose and centri- 
fuged at 105 000 X g for 60 min. The supematant 
was dialysed (Viking tubing 18132) under vacuum 
(400 mm Hg pressure). The dialysable material was 
concentrated to 0.1 vol. by lyophilisation. Mg’+, Ca2*, 
K’, Na’ and Cl- concentrations have been measured; 
they represented less than 5% optimal ionic concen. 
trations used for cell-free ~cubation where 0.1 vol. 
the concentrated dialysate was added to 1 vol. freshly 
prepared “S-20’ supernatant, 
2.5. Characterization of the t~ns[ation products 
In order to measure TAT synthesis, S-10 ml reac- 
tion mixture were incubated before being centrifuged 
at 100 000 X g for 90 min. The labelled TAT was 
selectively precipitated from the released soluble 
proteins using specific anti-tyrosine aminotransferase 
antibody and carrier TAT as in [8]. To control the 
amino acid incorporation, 25 fzi samples were removed 
and spotted on Whatman 3MM disks, and the acid- 
precipitable radioactivity was determined by the 
method in [9]. Synthesis of ferritin was measured 
by radioimmunoprecipitation as in [IO] . 
3. Results 
3.1. Influence of the origin of the polysomes 
The ‘S-20’ extracts prepared from dex~e~asone- 
induced or uninduced cultures were centrifuged in 
order to separate the poly~~somes from the 
105 000 X g supernatant fraction. The polyribosomes 
from both types of cells were resuspended in the 
supematant layer obtained from either induced or 
uninduced cells. The ‘recombined S-20’ were incubated 
and assayed for total amino acid incorporation, 
released polypeptides, TAT and ferritin synthesis. 
The amo~t of radi?a~ti~ty ~corpomted into total 
acid precipitable material by the ‘recombined S-20 
was ~-66% that incorporated by unfractionated 
extracts (results not shown); this decrease isprobably 
due to damage to polyribosomes or to their incomplete 
resuspension. 
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Fig. 1, Influence of the polyribosome fraction (P) and the 
105 000 X g su~rn~~t (S) from uninduced (U) and dexa- 
methasoneinduced (I) cells on the amino acid incorporation 
into proteins. TAT and ferritin synthesis were estimated by 
imm~oprecipitation in 1 ml or 2 ml sampies of the release 
as reported in section 2. The values are the mean of duplicate 
m~surements, 
As shown in fig. 1) for any recomb~ation, the 
labellings were very similar in total proteins, in the 
released proteins and in ferritin which was choosen 
as an internal uninducible protein control [lo] , The 
in~orporatiou into TAT was lo-times greater in the 
homologous recombined extract prepared from 
induced cells (Pi-S,) than in the corresponding 
preparation from uninduced cells (pU--S,). The 
activity of the cell-free systems reported here reflects 
the rate of TAT enzymic activity measured in whole 
ceils at the time the extracts were made. TAT synthesis 
carried out by heterologous recomb~ations was 
determined largely by the origin of the polyribosome 
fraction. Neve~heless, the source of supemat~t is 
not negligible. The addition of the supematant from 
induced cells (SI) to polysomes from uninduced cells 
(PU) led to a 2-fold increase of the basal level; this 
result could be due to some messenger moIecules in 
the supernat~t from induced cells or to a difference 
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Fig.2. Influence of dialysis of the ‘S-20’ 20 000 X g super- 
natant extract, The extracts from dexamethasone-induced 
cells were dialyzed twice for 30 mm (Visking tubing 18/32) 
against buffer A in the presence or in absence of hormone 
@ex) prior incubation with [ 3H]leucine. In the experiment 
represented in the Last column, the concentrated ialysate 
(X) was added for incubation as described in section 2.
in the concentration of some unknown supernatant 
component. When the supernat~t from u~duced 
cells was incubated with the poIysomal fraction from 
induced cells, the amount of TAT synthesized imin- 
ished by 40-50% relative to optimal synthesis (PI--S& 
Even so, TAT synthesis remains 4-5 times higher 
than the basal evel. 
3.2. &rfiuence of dialysis 
The dialysis of the induced ‘S-20’ extract dimin- 
ished the internal pool of amino acids and consequently 
led to a higher (a-fold) incorporation of labelled 
amino acids (fig.2). in these conditions the synthesis 
of ferritin remained const~t whereas TAT synthesis 
diminished significantly as compared to the control 
@O-60%). As the ma~tenance of specific protein 
synthesis might depend on the continuous presence 
of the inducing hormone, dialysis was conducted in 
the presence of dexarnethasone. Even in this case, 
TAT synthesis decreased in the same proportions. 
This result cannot be explained by a phenomenon of
rapid degradation of the specific mRNA for TAT in the 
absence of the inducing hormone as observed [1 l] 
for the ovalbumin mRNA after withdrawal of 
oestrogen. 
We next incubated the dialyzed ‘S-20’ extract from 
educed cells with a dialysate from induced cells. In 
these conditions, the specific rate of TAT was restored 
to the induced level (flg.2). When the dialysate was 
added to the ‘S-20’ extract from uninduced cells, we 
observed the same 2-3.fold increase in specific rate 
of TAT as that measured by adding the supernatant 
from induced cells to the polysomes from uninduced 
cells (pu-SI, fig.1). 
MS++piJ 
Fig.3. Dependence of TAT synthesis on Mg”’ concentration. 
Total protein synthesis (4 -----A) was measured by the 
amount of [3H]leucine incorporated. Specific synthesis of 
TAT (a- - -n) was measured by ~munoprecipi~tion and 
is expressed as % total protein synthesis for each given Mg* 
concentration (mean vahre of 3 different determinations). 
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Table 1 
Effect of spermine on protein synthesis 
Cellular origin [ Spermine] Radioactivity n % Total released 
of extract (mM) released polypeptides radioactivity n TAT 
(cpm/mg protein X 10b5) 
( 
cpminTATX 100 . 
cpm in total released proteins 
s20-I 2.6 0.20 
s20-I 5.1 0.11 
dialyzed 0.100 5.0 0.17 
0.200 3.7 0.16 
s20-U - 2.4 0.02 
0.100 2.3 0.04 
0.200 1.7 0.03 
‘S20’ extracts prepared from dexamethasone-induced (I) and control (U) cells were harvested with 
[ %]teucine and the radioa~ivity nto the released protein fraction was determined as indicated in 
section 2. The radioactivity ncorporated into TAT was measured by ~munoprecipitation as i  [9] 
3.3. Nature of the dialysable component 4. Discussion 
Only circumstantial evidence can be provided about 
the real nature of the active component. It could not 
be precipitated with ethanol even in the presence of 
carrier RNA. The component resisted heating for 
5 min at 8O’C. Mixing with Norite 1121, which nor- 
mally binds nucleotides, did not retain the dialysable 
activity; these observations weigh against an involve- 
ment of small molecular weight RNAs as described 
113,141. 
Since the u~denti~ed component was dialysable, 
its molecular weight must be relatively low. In view 
of these results and in connection with reports [15 ,I 61 
dealing with the stimulatory activity of polyamines 
in cell-free protein biosynthesis, we investigated the 
effect of spermine in our system, Spermine was 
assayed at the MgF concent~tion yielding m~imum 
synthesis of TAT which also yields maximum incor- 
poration of leucine into total proteins (fig.3). Table 1 
shows that 1 mM spermine restored almost he activity 
of the dialyzed induced ‘S-20’ extract. Nevertheless ’ 
spermine was less active than the dialysable compo- 
nent. Over 0.1 mM, spermine i~bited total protein 
synthesis. 
In vivo experiments had suggested that an accumu- 
lation of TAT-specific RNA 1171 and an increase in 
the concentration of ribosomes engaged in TAT 
synthesis [ 181 occur on induction. These results 
imply that the concentration of active TAT mRNA 
is elevated in the induced state. The experiments 
described in the present paper are in accord with this 
idea, since the polyribosome fraction from induced 
cells is more active in cell-free TAT synthesis than 
the same fraction from uninduced cells, irrespective 
of supematant content. 
Our results indicate less translation (40--W%) 
of mRNA coding for TAT in the polysomes of I-ITC 
cells in the presence of 105 000 X g supernatant from 
un~duced cells or from induced HTC cells when the 
supernatant was pre-dialyzed. A similar lack of stimu- 
lation was observed with the supematant from Zajdela 
hepatoma cells which are not inducible [ 191. It is 
possible to restore the activity of the dialyzed extracts 
by adding back the concentrated dialysate to the 
~cubation mixture. It therefore appears that the 
level of TAT synthesis may be regulated by compo- 
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nents other than the level of the specific mRNA for 
TAT. A positive translational stimulation of the TAT- 
mRNA superimposed on the transcriptional control 
might’explain these observations. 
The active soluble component(s) could be linked 
to the.activity of poly~ines. However, spermine, 
which is the most effective and acts at the lowest 
concentration for the in vitro synthesis of albumin 
[20] , did not appear as active as the dialysable 
component i self. But spermine could require differ” 
ent MgF concentrations for optimal TAT synthesis and 
total protein synthesis as observed for various proteins 
in other systems [20-223% Involvement of poly- 
amines in hormonal effects have been shown not only 
in vitro but also in viva, especially during milk protein 
synthesis [23] s Further experiments would be neces- 
sary to investigate whether a hormonal control of 
polyamine synthesis (spermine, spermidine or put- 
rescine) exists in HTC cells under glucocorticoid 
treatment. 
Another question remains to be solved: at which 
step is the soluble component operative? The trans- 
lational control of TAT synthesis could be elicited 
theoretic~ly at initiation, elongation or termination, 
The synthesis of most major proteins is limited by 
initiation. In our post-mitochondrial hepatoma cell 
system, essentially completion of nascent TAT chains 
was occurring as aurin-tricarboxylic acid used at 
0.1 mM, where it inhibits only initiation [24], leads 
to only a IO- 15% i~bition of the endogeneous 
protein synthesis. Thus, the active dialysable compo- 
nent probably acts at a step other than initiation. In 
order to clarify this point, we measured more complete 
TAT-mRNA translation in a heterologous cell-free 
system which is described in [2.5] ,
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